Lite Strategy, Inc. Increase (Decrease) in Receivables
Lite Strategy, Inc. (LITS) reported Increase (Decrease) in Receivables of -$2.21 million for the 6-month period ending 2020-12-31, per its 10-Q filed 2021-02-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2021-02-04
- Lite Strategy, Inc. increase (decrease) in receivables for the quarter ending 2020-12-31 was $283.00K.
- Lite Strategy, Inc. increase (decrease) in receivables for the quarter ending 2020-09-30 was -$2.49M, a 863.19% decline year-over-year.
- Lite Strategy, Inc. increase (decrease) in receivables for the quarter ending 2020-06-30 was $2.53M.
- Lite Strategy, Inc. increase (decrease) in receivables for the quarter ending 2020-03-31 was -$22.00K, a 466.67% decline year-over-year.
- Lite Strategy, Inc. increase (decrease) in receivables for fiscal 2020 was $2.60M.
- Lite Strategy, Inc. increase (decrease) in receivables for fiscal 2019 was -$82.00K.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 12 month |
|---|---|---|---|---|
| 2020-12-31 | $283.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-04 | -$2.21M 10-Q · filed 2021-02-04 | $326.00K derived: sum of 3 quarters · filed 2021-02-04 | $304.00K derived: sum of 4 quarters · filed 2021-02-04 |
| 2020-09-30 | -$2.49M 10-Q · filed 2020-11-10 | $43.00K derived: sum of 2 quarters · filed 2020-11-10 | $21.00K derived: sum of 3 quarters · filed 2020-11-10 | -$209.00K derived: sum of 4 quarters · filed 2021-02-04 |
| 2020-06-30 | $2.53M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-09 | $2.51M derived: sum of 2 quarters · filed 2020-09-09 | $2.28M derived: sum of 3 quarters · filed 2021-02-04 | $2.60M 10-K · filed 2020-09-09 |
| 2020-03-31 | -$22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-07 | -$252.00K derived: sum of 2 quarters · filed 2021-02-04 | $74.00K 10-Q · filed 2020-05-07 | -$59.00K derived: sum of 4 quarters · filed 2021-02-04 |
| 2019-12-31 | -$230.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-04 | $96.00K 10-Q · filed 2021-02-04 | -$37.00K derived: sum of 3 quarters · filed 2021-02-04 | -$31.00K derived: sum of 4 quarters · filed 2021-02-04 |
| 2019-09-30 | $326.00K 10-Q · filed 2020-11-10 | $193.00K derived: sum of 2 quarters · filed 2020-11-10 | $199.00K derived: sum of 3 quarters · filed 2020-11-10 | $113.00K derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | -$133.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-09 | -$127.00K derived: sum of 2 quarters · filed 2020-09-09 | -$213.00K derived: sum of 3 quarters · filed 2020-09-09 | -$82.00K 10-K · filed 2020-09-09 |
| 2019-03-31 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-09 | -$80.00K derived: sum of 2 quarters · filed 2019-05-09 | $51.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-07 | $45.00K 10-Q · filed 2019-02-07 | ||
| 2018-09-30 | $131.00K 10-Q · filed 2018-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |